Posts Tagged ‘patent expiration’

New patent expiration for Osi Pharms drug TARCEVA

Annual Drug Patent Expirations for TARCEVA Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Osi Pharms drug TARCEVA appeared first on Drug…


New patent expiration for DORC drug MEMBRANEBLUE

Annual Drug Patent Expirations for MEMBRANEBLUE Membraneblue is a drug marketed by Dorc and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent expiration for DORC drug MEMBRANEBLUE appeared …


New patent expiration for DORC drug VISIONBLUE

Annual Drug Patent Expirations for VISIONBLUE Visionblue is a drug marketed by Dorc and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent expiration for DORC drug VISIONBLUE appeared first …


New patent expiration for Wyeth Pharms drug DUAVEE

Annual Drug Patent Expirations for DUAVEE Duavee is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Wyeth Pharms drug DUAVEE appeared first on Dr…


Drug Patent Expirations for the Week of April 28, 2019

PROMACTA (eltrombopag olamine) Novartis pharms corp Patent: 6,280,959 Expiration: Apr 30, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expiratio…


New patent expiration for Novartis Pharms drug PROMACTA KIT

Annual Drug Patent Expirations for PROMACTA+KIT Promacta Kit is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Novartis Pharms drug PROMACTA KIT appea…


New patent expiration for Novartis Pharms drug PROMACTA

Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are thirteen…
The post New patent expiration for Novartis Pharms drug PROMACTA appear…


Patent delisted for Astellas drug LEXISCAN

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post Patent delisted for Astellas drug LEXISCAN appeared firs…


New patent expiration for Galderma Labs drug SOOLANTRA

Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Galderma Labs drug SOOLANTRA appeared firs…


New patent expiration for Galderma Labs drug SOOLANTRA

Annual Drug Patent Expirations for SOOLANTRA Soolantra is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Galderma Labs drug SOOLANTRA appeared firs…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog